Param Proteins Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.08 Cr
- Satisfied Charges ₹ 1.50 M
- Revenue Growth -39.03%
- Profit Growth -52.19%
- Ebitda 16.92%
- Net Worth 16.75%
- Total Assets 70.29%
About Param Proteins
Param Proteins Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 April 2019 (Five years and ten months 14 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.08 Cr. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Khushbu Thakkar and Achint Thakkar serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15490GJ2019PTC107520
- Company No.
107520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Param Proteins?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khushbu Thakkar  | Director | 08-Apr-2019 | Current |
| Achint Thakkar | Director | 08-Apr-2019 | Current |
Financial Performance of Param Proteins.
Param Proteins Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.03% decrease. The company also saw a substantial fall in profitability, with a 52.19% decrease in profit. The company's net worth Soared by an impressive increase of 16.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Param Proteins?
In 2023, Param Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.82 M
₹1.50 M
Charges Breakdown by Lending Institutions
- Others : 2.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2024 | Others | ₹2.00 Cr | Open |
| 30 Jul 2024 | Others | ₹0.82 M | Open |
| 11 Nov 2022 | Others | ₹1.50 M | Satisfied |
How Many Employees Work at Param Proteins?
Unlock and access historical data on people associated with Param Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Param Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Param Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.